Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | PAM | P19021 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 3/20 | 0.46 |
| ▸ | CES1 | P23141 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 5/20 | 0.46 |
| ▸ | PPARG | P37231 | 6/20 | 0.45 |
| ▸ | PPARD | Q03181 | 6/20 | 0.45 |
| ▸ | PPARA | Q07869 | 6/20 | 0.45 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.45 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | TLR2 | O60603 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | FABP4 | P15090 | 2/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.45 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.45 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL688903 | 1.00 | DGKA (0.53) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL20576505 | 1.00 | DGKA (0.53) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL5446582 | 1.00 | DGKA (0.53) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL9172074 | 1.00 | DGKA (0.53) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL22711539 | 1.00 | DGKA (0.53) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL22833891 | 1.00 | DGKA (0.53) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL297943 | 1.00 | DGKA (0.53) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL16062122 | 1.00 | DGKA (0.53) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL297510 | 1.00 | DGKA (0.53) | DGKALMNAPAMMAPTMAPK1 | |
| SCHEMBL3693303 | 1.00 | DGKA (0.53) | DGKALMNAPAMMAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2288416-B2 | HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS | GOJO IND INC (US) | 2014-12-24 | — | — | EP | claimed |
| US-8822547-B2 | Hydroalcoholic gel compositions for use with dispensers | GOJO INDUSTRIES, INC. (US) | 2014-09-02 | — | — | US | claimed |
| EP-2460560-A1 | Hydroalcoholic gel compositions for use with dispensers | Gojo Industries, Inc. (US) | 2012-06-06 | — | — | EP | claimed |
| EP-2288416-B1 | HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS | GOJO IND INC (US) | 2012-02-29 | — | — | EP | claimed |
| US-20110144214-A1 | HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS | SILVER POINT FINANCE, LLC, AS COLLATERAL AGENT | 2011-06-16 | — | — | US | claimed |
| EP-2288416-A2 | HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS | GOJO Industries, Inc. (US) | 2011-03-02 | — | — | EP | claimed |
| WO-2009058802-A2 | HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS | GOJO INDUSTRIES, INC. (US) | 2009-05-07 | — | — | WO | claimed |
| EP-4688725-A1 | FATTY ACID ESTERS OF HYDROXY FATTY ACID | Wilmar International Limited (SG) | 2026-02-11 | — | — | EP | disclosed |
| US-20250009682-A1 | PATCH | KANEKA CORPORATION (JP) | 2025-01-09 | — | — | US | disclosed |
| WO-2024205503-A1 | FATTY ACID ESTERS OF HYDROXY FATTY ACID | WILMAR INTERNATIONAL LIMITED (SG) | 2024-10-03 | — | — | WO | disclosed |
| CN-118317769-A | Patch agent | 株式会社钟化 | 2024-07-09 | — | — | CN | disclosed |
| US-20230414512-A1 | Dermal Delivery Compositions Comprising Active Agent-Calcium Phosphate Particle Complexes and Methods of Using the Same | LABORATORY SKIN CARE, INC. | 2023-12-28 | — | — | US | disclosed |
| EP-4218718-A2 | DERMAL DELIVERY COMPOSITIONS COMPRISING ACTIVE AGENT-CALCIUM PHOSPHATE PARTICLE COMPLEXES AND METHODS OF USING THE SAME | Laboratory Skin Care, Inc. (US) | 2023-08-02 | — | — | EP | disclosed |
| US-20090196894-A1 | Self Tanning Composition | CIBA CORP. | 2009-08-06 | — | — | US | disclosed |
| WO-2009058802-A2 | HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS | GOJO INDUSTRIES, INC. (US) | 2009-05-07 | — | — | WO | disclosed |
| US-20090068255-A1 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | LIVING PROOF, INC. | 2009-03-12 | — | — | US | disclosed |
| EP-2026746-A2 | SELF TANNING COMPOSITION | Ciba Holding Inc. (CH) | 2009-02-25 | — | — | EP | disclosed |
| WO-2009016064-A1 | USE OF NANODISPERSIONS TO PROTECT WATER-SOLUBLE INGREDIENTS IN COSMETIC END FORMULATIONS | BASF SE (CH) | 2009-02-05 | — | — | WO | disclosed |
| WO-2008134712-A2 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | LIVING PROOF, INC. (US) | 2008-11-06 | — | — | WO | disclosed |
| WO-2007137958-A2 | SELF TANNING COMPOSITION | CIBA HOLDING INC. (CH) | 2007-12-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110144214-A1 | HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS | ADH1A, ADH1C, ADH5 | DGKA 60/4885LMNA 4383/4885PAM 740/4885 |
| US-20090068255-A1 | USE OF MATRIX METALLOPROTEINASE INHIBITORS IN SKIN CARE | MMP1, MMP9, MMP17 | DGKA 3859/4885LMNA 45/4885PAM 2413/4885 |
| US-20090196894-A1 | Self Tanning Composition | C9, KRT18, F12 | DGKA 2047/4885LMNA 657/4885PAM 2245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.